CNE000000WF9
CNE000000WF9
BEIJING TIANTAN BIOLOGICAL PROD
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 6.168.036.315 | 6.031.865.460 | 2.3% |
| Cost of Revenue | 3.463.231.713 | 2.732.440.126 | 26.7% |
| Gross Profit | 2.704.804.602 | 3.299.425.335 | 18.0% |
| 812.333.152 | 778.159.390 | 4.4% | |
| Operating Income | 1.892.471.450 | 2.521.265.944 | 24.9% |
| Pretax Income | 1.822.723.792 | 2.547.217.503 | 28.4% |
| Net Income Common Stockholders | 1.090.837.981 | 1.549.164.832 | 29.6% |
| -- | -- | -- | |
| -- | -- | -- |